Oncology News Today

Oncology News Today The latest news and research for oncology HCPs. Sign up to our newsletter ⬇️
https://confirmsubscription.com/h/j/820ADA6F18DCD1F0

A team at the University of Oxford has received support from the Medical Research Council (MRC) to develop and manufactu...
03/06/2026

A team at the University of Oxford has received support from the Medical Research Council (MRC) to develop and manufacture a new generation of personalised cancer vaccines using artificial intelligence and UK sovereign AI systems.

The programme, called the UK Cancer Vaccine AI & Supercomputing Project, brings together doctors, cancer scientists, AI experts, robotics engineers and manufacturing specialists to build AI-designed personalised cancer vaccines.

The team has been developing biological AI models using the UK’s sovereign AI systems, including the DAWN and ISAMBARD-AI supercomputers. These systems allow researchers to analyse vast amounts of and immune data at a scale previously impossible within conventional university computing environments.

The MRC support will fund the next phase of the programme, including equipment needed to manufacture experimental mRNA cancer vaccines and test whether the AI’s predictions work in patient samples.

The aim is to determine whether vaccine targets selected by AI can generate strong anti-cancer immune responses.

Read more:

A team at the University of Oxford has received support from the Medical Research Council to develop and manufacture a new generation of personalised cancer vaccines using artificial intelligence and UK sovereign AI systems.

📰 NEWS: QEQM team introduce new bowel cancer surgery techniqueDavid Haddaway (pictured) had the procedure at the Queen E...
03/06/2026

📰 NEWS: QEQM team introduce new bowel cancer surgery technique

David Haddaway (pictured) had the procedure at the Queen Elizabeth The Queen Mother Hospital in Margate with consultant general and colorectal surgeon Mr Mohamed Boshnaq, after being diagnosed with bowel cancer.

Traditionally, surgeons would pull the bowel outside the body to remove the cancer and stitch it back together, and the team at QEQM are one of the first in Kent and the south east to offer the new technique. It is more technically demanding but has many benefits for patients, including a much smaller incision, reduced pain and a faster recovery.

Read more: https://oncologynewstoday.co.uk/qeqm-team-introduce-new-bowel-cancer-surgery-technique/

East Kent Hospitals University NHS Foundation Trust

A grandfather was one of the first in east Kent to have part of his bowel removed and reconnected inside his body.

📰 NEWS: Immunotherapy injection shrinks tumours in patients with recurrent and / or metastatic head and neck cancerNew r...
02/06/2026

📰 NEWS: Immunotherapy injection shrinks tumours in patients with recurrent and / or metastatic head and neck cancer

New results from phase Ib/II OrigAMI‑4 clinical trial, by scientists from The Institute of Cancer Research and presented on Sunday at the American Society of Clinical Oncology (ASCO) Annual Meeting, confirmed tumour shrinkage in 42 per cent of patients treated with the drug amivantamab, alongside encouraging survival outcomes in a group of patients who until now had very limited options. The results are based on blinded independent central review (BICR), where outcomes were checked by external experts who did not know which treatment each patient received, helping ensure the results are fair, unbiased, and reliable.

Read more: https://oncologynewstoday.co.uk/immunotherapy-injection-shrinks-tumours-in-patients-with-recurrent-and-or-metastatic-head-and-neck-cancer/

Pictured: Carl Walsh, one of the trial's participants.
Credit: Institute for Cancer Research/PA Wire

The Royal Marsden NHS

A targeted cancer treatment given via a simple injection under the skin shrank tumours in more than one third of patients with recurrent and / or metastatic head and neck cancer whose disease has stopped responding to standard treatments.

📰 NEWS: Urine test could help detect lung cancer years before symptoms occurCambridge scientists hunting tell-tale kille...
01/06/2026

📰 NEWS: Urine test could help detect lung cancer years before symptoms occur

Cambridge scientists hunting tell-tale killer ‘zombie’ cells that signal early lung cancer have developed a world-first urine test that could transform diagnosis and survival for thousands of patients.

As published last week in Nature Aging, the team has shown that this simple and affordable test could detect the earliest signs of lung cancer months, or even years, before symptoms appear, as well as monitor whether treatment is working and identify potential relapse.

The study, funded by Cancer Research UK, marks a major leap towards more precise therapy and a test for early cancer and treatment efficiency that could be rolled out across the NHS one day.

Read more:

Cambridge scientists hunting tell-tale killer ‘zombie’ cells that signal early lung cancer have developed a world-first urine test that could transform diagnosis and survival for thousands of patients.

📰 NEWS: National expert in geriatric care appointed to expand pioneering service at The Christie for older patientsThe C...
29/05/2026

📰 NEWS: National expert in geriatric care appointed to expand pioneering service at The Christie for older patients

The Christie NHS Foundation Trust in Manchester has appointed Professor Martin Vernon, a nationally recognised expert in older people’s care, to help develop its Senior Adult Oncology Service. The service, launched 3 years ago, is already one of only a small number of dedicated programmes worldwide focused on supporting older cancer patients with frailty and complex health needs.

The medical oncologist, Dr Fabio Gomes, founder and co-lead for the Senior Adult Oncology programme at The Christie said: “Since launching our Senior Adult Oncology Service, we have seen first-hand the positive difference that specialist, multidisciplinary support can make for those more complex older patients with cancer living with frailty and multiple health conditions."

Read more: https://oncologynewstoday.co.uk/national-expert-in-geriatric-care-appointed-to-expand-pioneering-service-at-the-christie-for-older-patients/

The Christie Charity

One of Europe’s leading cancer centres has appointed a specialist geriatrician to strengthen its pioneering service for older patients, as the NHS seeks to adapt to the growing challenge of an ageing population.

📰 NEWS: New study traces rare form of childhood leukaemia back to before birthA team of scientists has uncovered new evi...
28/05/2026

📰 NEWS: New study traces rare form of childhood leukaemia back to before birth

A team of scientists has uncovered new evidence that some cases of a subtype of childhood leukaemia may develop before birth, shedding light on how the disease evolves over time.

The study, led by ongoing collaboration between The Institute of Cancer Research (ICR), the Karolinska Institutet and Uppsala University in Sweden, represents the first systemic analysis of neonatal blood spots taken at birth from children who later developed a rare subtype of paediatric acute lymphoblastic leukaemia (ALL) called iAMP21.

The work was funded by The Institute of Cancer Research, London – which is both a research institute and a charity – and the Swedish Childhood Cancer Society. The findings have been published in the journal Haematologica.

Read more: https://oncologynewstoday.co.uk/smc-recommends-combination-metastatic-bladder-cancer-therapy-following-strong-clinical-trial-outcomes-2/

Barncancerfonden

A team of scientists has uncovered new evidence that some cases of a subtype of childhood leukaemia may develop before birth, shedding light on how the disease evolves over time.

📰 NEWS: A microscopic pattern in tumour cells – rarely reported until recently – could influence how doctors decide who ...
26/05/2026

📰 NEWS: A microscopic pattern in tumour cells – rarely reported until recently – could influence how doctors decide who may benefit from robotic surgery, according to cancer specialists at UCLH - University College London Hospitals NHS Foundation Trust.

A specific arrangement of prostate cancer cells called cribriform pattern tends to point to a more dangerous or aggressive type of cancer and could influence the decision to treat early tumours with surgery, UCLH cancer surgeons have said.

Read more:

A microscopic pattern in tumour cells – rarely reported until recently – could influence how doctors decide who may benefit from robotic surgery, according to cancer specialists at University College London Hospitals NHS Foundation Trust (UCLH).

📰 NEWS: Scientists discover how lung cancer spreads in its later stagesResearchers at UCL and UCLH - University College ...
22/05/2026

📰 NEWS: Scientists discover how lung cancer spreads in its later stages

Researchers at UCL and UCLH - University College London Hospitals NHS Foundation Trust, working with colleagues at The Francis Crick Institute, have discovered how lung cancer spreads in the final stages of the disease, a finding that could help doctors treat advanced lung cancer more effectively.

The study, published in the journal Nature, analysed more than 500 tissue samples from 24 patients who died from advanced lung cancer. It found that tumours which had spread to other parts of the body were themselves seeding new tumours, driving the cancer further. In over half of cases studied, this chain of spread was observed.

This research was funded by Cancer Research UK.

Read more:

Researchers at UCL and University College London Hospitals NHS Foundation Trust, working with colleagues at the Francis Crick Institute, have discovered how lung cancer spreads in the final stages of the disease, a finding that could help doctors treat advanced lung cancer more effectively.

📰 NEWS: Men with localised prostate cancer could benefit from a shorter course of radiotherapy, after new research data ...
21/05/2026

📰 NEWS: Men with localised prostate cancer could benefit from a shorter course of radiotherapy, after new research data shows that just two higher-dose treatments are as safe as a standard five-session regimen, with no increase in side effects.

The findings from the HERMES study, led by The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust were presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO) in Stockholm.

Read more:

Men with localised prostate cancer could benefit from a shorter course of radiotherapy, after new research data shows that just two higher-dose treatments are as safe as a standard five-session regimen, with no increase in side effects.

📰 NEWS: New research has endorsed a long‑standing idea explaining why acute lymphoblastic leukaemia (ALL) – the most com...
20/05/2026

📰 NEWS: New research has endorsed a long‑standing idea explaining why acute lymphoblastic leukaemia (ALL) – the most common cancer in children – appears abruptly in early life, often in otherwise healthy individuals, with no obvious environmental trigger.

The new study, carried out by researchers at The Institute of Cancer Research, London, has provided some of the clearest experimental evidence yet that when children encounter everyday microbes may be just as important as whether they do.

Read more:

New research has endorsed a long‑standing idea explaining why acute lymphoblastic leukaemia (ALL) – the most common cancer in children – appears abruptly in early life, often in otherwise healthy individuals, with no obvious environmental trigger.

Address

Catherine House, Harborough Road
Brixworth
NN69BX

Telephone

+441604882342

Website

Alerts

Be the first to know and let us send you an email when Oncology News Today posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Oncology News Today:

Shortcuts

Share

Category